Autologous Skin Fibroblast‐Based PLGA Nanoparticles for Treating Multiorgan Fibrosis

Fibrotic diseases remain a substantial health burden with few therapeutic approaches. A hallmark of fibrosis is the aberrant activation and accumulation of myofibroblasts, which is caused by excessive profibrotic cytokines. Conventional anticytokine therapies fail to undergo clinical trials, as simp...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Qiang, Liu, Zehua, Shao, Qianwen, Shi, Hongpeng, Huang, Shixing, Jiang, Chenyu, Qian, Bei, Zhong, Yiming, He, Xiaojun, Xiang, Xiaogang, Yang, Yang, Li, Bing, Yan, Xiaoxiang, Zhao, Qiang, Wei, Xiaoli, Santos, Hélder A., Ye, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313479/
https://www.ncbi.nlm.nih.gov/pubmed/35603964
http://dx.doi.org/10.1002/advs.202200856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313479/
https://www.ncbi.nlm.nih.gov/pubmed/35603964
http://dx.doi.org/10.1002/advs.202200856

Ejemplares similares